DLBS1449 in Diabetic Patients With Low HDL

NCT01972477 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Diabetic Patients
Low HDL-cholesterol (< 35 mg/dL)
Lifestyle Intervention for at Least 1 Month

Interventions

DRUG: DLBS1449
OTHER: Placebo

Sponsor

Dexa Medica Group